POLARISqb will revolutionize drug design by joining Quantum Computing with AI and Precision Medicine. Our platform will produce up to 100 drug blueprints per year. We will compress the lead time for preclinical drug candidates from 5 years to 4 months, enabling real time adaptability to the precision medicine market. POLARISqb will own an IP portfolio of drug assets to license, sell, or develop internally.